- Investing Ideas
- Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Swiss Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
13
Mid-Large Cap Stocks
13 companies
Roche Holding
Market Cap: CHF 261.4b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 319.00
7D
-1.9%
1Y
22.7%
Novartis
Market Cap: CHF 221.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 118.04
7D
-2.9%
1Y
24.0%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 148.90
7D
-1.8%
1Y
-7.7%
Bachem Holding
Market Cap: CHF 5.0b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 67.00
7D
1.0%
1Y
16.9%
Sandoz Group
Market Cap: CHF 29.8b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 67.68
7D
2.5%
1Y
55.2%
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 66.50
7D
-4.0%
1Y
18.1%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 48.95
7D
0.7%
1Y
-31.6%
Galderma Group
Market Cap: CHF 40.5b
Operates as a dermatology company worldwide.
GALD
CHF 172.60
7D
2.4%
1Y
54.0%
Dottikon ES Holding
Market Cap: CHF 4.1b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries.
DESN
CHF 296.00
7D
3.3%
1Y
1.9%
Lonza Group
Market Cap: CHF 34.5b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 491.60
7D
-0.08%
1Y
-11.9%
Siegfried Holding
Market Cap: CHF 2.9b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 67.00
7D
-11.1%
1Y
-28.7%
Idorsia
Market Cap: CHF 1.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 5.85
7D
29.0%
1Y
202.8%
PolyPeptide Group
Market Cap: CHF 1.2b
Operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
PPGN
CHF 37.30
7D
8.9%
1Y
84.7%